Vera Therapeutics Inc (VERA)

04:54 AM

[8-K] Vera Therapeutics, Inc. Reports Material Event - Stock Titan

04:54 AM

04:24 AM

Director at Vera Therapeutics (VERA) receives 17,084 stock options with $34.35 strike - Stock Titan

04:24 AM

04:22 AM

[Form 4] Vera Therapeutics, Inc. Insider Trading Activity - Stock Titan

04:22 AM

04:22 AM

Vera Therapeutics (VERA) director Beth Seidenberg receives 17,084-share stock option grant - Stock Titan

04:22 AM

04:20 AM

Director at Vera Therapeutics (VERA) receives grant of 17,084 options - Stock Titan

04:20 AM

04:19 AM

Vera Therapeutics grants 17,084-share option to director | VERA Insider Trading - Stock Titan

04:19 AM

04:18 AM

Vera Therapeutics (VERA) director awarded options on 17,084 shares - Stock Titan

04:18 AM

04:17 AM

Vera Therapeutics (VERA) awards director 17,084 stock options - Stock Titan

04:17 AM

04:15 AM

Director Patrick Enright awarded 17,084 Vera Therapeutics (VERA) stock options - Stock Titan

04:15 AM

02:29 AM

Investment Firm Closes Out Entire $18.1 Million Position in Biotech Stock, According to Latest SEC Filing - The Motley Fool

02:29 AM

May 23, 2026

J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $86 - Moomoo

May 23, 2026

May 22, 2026

BofA Securities Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $65 - Moomoo

May 22, 2026

May 22, 2026

Vera Therapeutics (VERA) Is Down 11.6% After Wider Q1 Loss Highlights Rising Cost Burden - Sahm

May 22, 2026

May 19, 2026

VERA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

May 19, 2026

May 19, 2026

VERA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

May 19, 2026

May 17, 2026

Vera Therapeutics, Inc.Class A Common Stock (NQ: VERA - FinancialContent

May 17, 2026

May 16, 2026

UBS Group AG Boosts Position in Vera Therapeutics, Inc. $VERA - MarketBeat

May 16, 2026

May 16, 2026

Why (VERA) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 16, 2026

May 15, 2026

T. Rowe Price (VERA) reports 4.57M shares, 6.4% ownership (Amendment) - Stock Titan

May 15, 2026

May 15, 2026

Evercore Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $91 - Moomoo

May 15, 2026

May 13, 2026

Vera Therapeutics president and CEO sells $679,747 in stock By Investing.com - Investing.com Canada

May 13, 2026

May 13, 2026

Vera Therapeutics president and CEO sells $679,747 in stock - Investing.com UK

May 13, 2026

May 13, 2026

Vera Therapeutics (VERA) CEO sells 18,500 shares under 10b5-1 plan - Stock Titan

May 13, 2026

May 13, 2026

H.C. Wainwright Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $110 - Moomoo

May 13, 2026

May 12, 2026

[144] Vera Therapeutics, Inc. SEC Filing - Stock Titan

May 12, 2026

May 12, 2026

Vera Therapeutics (VERA) Receives a Buy from Guggenheim - The Globe and Mail

May 12, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

Guggenheim Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $56 - Moomoo

May 11, 2026

May 10, 2026

The Bull Case For Vera Therapeutics (VERA) Could Change Following Atacicept’s FDA Priority Review And Ramp-Up - Yahoo! Finance Canada

May 10, 2026

May 10, 2026

A Look At Vera Therapeutics (VERA) Valuation After FDA Priority Review For Atacicept In IgA Nephropathy - Sahm

May 10, 2026

May 09, 2026

Does Vera’s Widening Quarterly Net Loss Reframe the Bull Case for Vera Therapeutics (VERA)? - Sahm

May 09, 2026

May 08, 2026

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 08, 2026

May 08, 2026

Vera Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - marketscreener.com

May 08, 2026

May 08, 2026

Vera Therapeutics announces inducement grants under Nasdaq listing rule 5635(C)(4) - TradingView

May 08, 2026

May 08, 2026

Ten new hires get Vera stock awards tied to 60,375 shares - Stock Titan

May 08, 2026

May 08, 2026

TD Cowen Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $73 - Moomoo

May 08, 2026

May 07, 2026

Vera Therapeutics : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

May 07, 2026

May 07, 2026

Vera Therapeutics | 10-Q: Q1 2026 Earnings Report - Moomoo

May 07, 2026

May 07, 2026

Vera Therapeutics (VERA) ramps spending as atacicept nears key FDA decision - Stock Titan

May 07, 2026

May 07, 2026

LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $90 - Moomoo

May 07, 2026

May 07, 2026

Vera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

Vera Therapeutics, Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

Kidney disease drug gets July 7 FDA date as Vera readies launch - Stock Titan

May 07, 2026

May 07, 2026

Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - marketscreener.com

May 07, 2026

May 07, 2026

Press Release: Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - Moomoo

May 07, 2026

May 06, 2026

Vera Therapeutics faces earnings test ahead of FDA verdict - Investing.com UK

May 06, 2026

May 06, 2026

Vera Therapeutics faces earnings test ahead of FDA verdict By Investing.com - Investing.com South Africa

May 06, 2026